ESC 365 - A patient with HF and LVEF > 40%: SGLT2 inhibitors.

ESC Professional Premium Access

A patient with HF and LVEF > 40%: SGLT2 inhibitors.

Session: How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%

Topic: Treatment

Speaker: Professor J. McMurray (Glasgow, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

127 presentations

21 followers

3 more presentations in this session

A patient with HF and LVEF > 40%: neurohumoral modulators.

Speaker: Professor S. Solomon (Boston, US)

A patient with HF and LVEF > 40%: exercise training.

Speaker: Associate Professor E. Van Craenenbroeck (Antwerp, BE)

Putting it all together: what to do for a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%.

Speaker: Professor M. Jessup (Dallas, US)

Access the full session

How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%

Speakers: Professor J. McMurray, Professor S. Solomon, Associate Professor E. Van Craenenbroeck, Professor M. Jessup

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources